---

---

symbols : BHC    crawled time : 13:00   

save search

---

Bausch Health Announces Third-Quarter 2023 Results
Published: 2023-11-02 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 22.74% | O: 3.81% H: 1.5% C: -0.14%
health results

---

Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
Published: 2023-11-01 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 27.42% | O: -0.59% H: 9.88% C: 4.42%
results

---

Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 25.76% | O: -0.72% H: 1.02% C: -1.9%
health

---

Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 17.59% | O: 0.0% H: 0.81% C: -1.35%
health results

---

Salix Pharmaceuticals Partners with Bellamy Young
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 8.49% | O: 0.25% H: 0.37% C: -0.12%
pharmaceuticals

---

Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
Published: 2023-09-11 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 0.58% | O: 1.04% H: 0.0% C: -0.57%
acquisition

---

Kessler Topaz Meltzer & Check, LLP: Deadline Reminder for Futu Holdings Limited (FUTU) Investors
Published: 2023-08-07 (Crawled : 13:00) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -4.08% | O: 1.1% H: 2.62% C: -3.6%
FUTU | $54.76 -0.16% -0.16% 680K |

Technology Services

| -6.85% | O: -2.15% H: 0.0% C: 0.0%
deadline

---

Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
Published: 2023-07-13 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 2.12% | O: 0.71% H: 0.35% C: -1.98%
health results

---

Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
Published: 2023-07-11 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -0.46% | O: 1.26% H: 1.02% C: -2.15%
health program gastrointestinal

---

Bausch Health Enters Into $600 Million Financing Facility With KKR
Published: 2023-07-07 (Crawled : 13:00) - biospace.com/
KKR | $92.62 -0.78% 0.0% 4.5M |

Finance

| 71.8% | O: -0.54% H: 3.25% C: 2.33%
HLI 4 | $123.77 1.14% 0.0% 330K |

Finance

| 30.5% | O: -0.06% H: 0.96% C: 0.51%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 13.0% | O: 0.39% H: 11.27% C: 8.03%
health

---

OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference
Published: 2023-07-07 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 13.0% | O: 0.39% H: 11.27% C: 8.03%
conference association dental research technology

---

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
Published: 2023-06-30 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 10.98% | O: 1.15% H: 3.72% C: 1.01%
acquire

---

Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
Published: 2023-06-19 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| Email alert Add to watchlist
liver international research

---

New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
Published: 2023-05-18 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 16.33% | O: 1.74% H: 12.96% C: 12.63%
pathogens study

---

Bausch Health to Announce First-Quarter 2023 Results on May 4
Published: 2023-04-13 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 17.75% | O: 1.49% H: 3.07% C: 0.67%
health results

---

Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
Published: 2023-02-23 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 0.58% | O: 4.05% H: 13.79% C: 9.57%
health results

---

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results
Published: 2023-02-22 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| -1.92% | O: -0.23% H: 3.0% C: -2.26%
CLSD P | $1.29 -2.27% -2.33% 230K |

Health Technology

| -4.38% | O: 0.73% H: 2.9% C: -3.62%
results

---

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K |

n/a

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $86.918 3.3% 60K |

n/a

| -10.99% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K |

n/a

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| 15.53% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.71% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $63.676 -4.38% 7.2K |

Manufacturing

| 64.2% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -37.34% | O: 3.43% H: 0.0% C: -2.93%
VTRS A | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 1.08% | O: 0.54% H: 2.5% C: 1.7%
NVO | News | $122.71 -0.03% 0.17% 5M |

Health Technology

| -9.33% | O: 1.43% H: 0.84% C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 4.01% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -16.27% | O: -0.28% H: 1.26% C: 1.15%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.12% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 38.38% | O: 0.48% H: 3.96% C: -0.48%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 2.97% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.26% | O: 0.16% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 2.39% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

---

First tazarotene lotion treatment for acne vulgaris, ARAZLO TM (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans
Published: 2022-12-22 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 25.76% | O: -1.3% H: 0.73% C: -4.25%
treatment drug acne

---

Outlook on the Age-related Macular Degeneration Global Market to 2030 - Players Include Bayer, Pfizer, Bausch Health and Amgen Among Others
Published: 2022-12-14 (Crawled : 13:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 23.48% | O: 1.74% H: 0.45% C: -1.8%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 3.45% | O: 1.0% H: 1.29% C: 0.45%
BHC | $8.69 1.05% 0.0% 2.9M |

Health Technology

| 12.71% | O: -0.39% H: 3.26% C: 2.34%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -1.22% | O: -0.11% H: 0.51% C: -0.31%
global macular health market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---